D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Genetics and Molecular Biology D-index 70 Citations 22,724 168 World Ranking 1488 National Ranking 766
Medicine D-index 77 Citations 37,933 172 World Ranking 10897 National Ranking 5819

Overview

What is she best known for?

The fields of study she is best known for:

  • Gene
  • Cancer
  • DNA

Cancer research, Leukemia, Myeloid leukemia, Molecular biology and Genetics are her primary areas of study. The concepts of her Cancer research study are interwoven with issues in Haematopoiesis, Stem cell, microRNA, Lymphoma and Myeloid-Lymphoid Leukemia Protein. The Leukemia study combines topics in areas such as Myeloid and Pathology.

Her study in Myeloid leukemia is interdisciplinary in nature, drawing from both Progenitor cell, Chromosome 7, Genetic testing and Gene expression profiling. Her Molecular biology study combines topics in areas such as Fluorescence in situ hybridization, Prostate, Proto-oncogene tyrosine-protein kinase Src and Cell cycle checkpoint. Her Acute leukemia research is multidisciplinary, incorporating perspectives in Myeloproliferative neoplasm, Acute erythroid leukemia, Atypical chronic myeloid leukemia and Intensive care medicine.

Her most cited work include:

  • The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia (3662 citations)
  • The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes (3594 citations)
  • Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia (2799 citations)

What are the main themes of her work throughout her whole career to date?

Michelle M. Le Beau mainly focuses on Cancer research, Genetics, Molecular biology, Leukemia and Myeloid leukemia. Her study on Cancer research also encompasses disciplines like

  • Haematopoiesis and related Bone marrow,
  • microRNA and related Ectopic expression. As a part of the same scientific family, Michelle M. Le Beau mostly works in the field of Molecular biology, focusing on Fluorescence in situ hybridization and, on occasion, Contig.

Her Leukemia research integrates issues from Myeloid, Trisomy and Chromosomal translocation. Her Myeloid leukemia course of study focuses on Oncology and Disease. She specializes in Immunology, namely Acute leukemia.

She most often published in these fields:

  • Cancer research (32.34%)
  • Genetics (29.04%)
  • Molecular biology (30.36%)

What were the highlights of her more recent work (between 2012-2020)?

  • Cancer research (32.34%)
  • Myeloid (24.42%)
  • Myeloid leukemia (25.74%)

In recent papers she was focusing on the following fields of study:

Michelle M. Le Beau focuses on Cancer research, Myeloid, Myeloid leukemia, Leukemia and Immunology. Her Cancer research research is multidisciplinary, incorporating elements of Haematopoiesis, Carcinogenesis, microRNA, Regulation of gene expression and Bone marrow. Her studies in Myeloid leukemia integrate themes in fields like SOX4, Molecular biology, NPM1, Promyelocytic leukemia protein and RUNX1T1.

Leukemia is a subfield of Internal medicine that Michelle M. Le Beau explores. Her biological study spans a wide range of topics, including Cancer, Anemia, Overall survival, Prognostic classification and Risk stratification. Her Myelodysplastic syndromes study deals with Intensive care medicine intersecting with Acute leukemia, Myeloproliferative neoplasm, Acute erythroid leukemia and Atypical chronic myeloid leukemia.

Between 2012 and 2020, her most popular works were:

  • The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia (3662 citations)
  • Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia (2799 citations)
  • Replication stress is a potent driver of functional decline in ageing haematopoietic stem cells (362 citations)

In her most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • DNA

Her primary areas of study are Myeloid leukemia, Leukemia, Immunology, Cancer research and Myeloid. Her Myeloid leukemia study incorporates themes from Mutation, Haploinsufficiency, International working group and Gerontology. The various areas that Michelle M. Le Beau examines in her Leukemia study include Molecular biology, Cancer, Bone marrow and Downregulation and upregulation.

Her Immunology study integrates concerns from other disciplines, such as Internal medicine and Oncology. Her studies in Cancer research integrate themes in fields like Insertional mutagenesis, Haematopoiesis, Carcinogenesis, microRNA and Locus. The various areas that Michelle M. Le Beau examines in her Myelodysplastic syndromes study include Myeloid Neoplasm, Myeloproliferative neoplasm, Intensive care medicine and Acute leukemia.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

Daniel A. Arber;Attilio Orazi;Robert Hasserjian;Jürgen Thiele.
Blood (2016)

5874 Citations

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

James W. Vardiman;Jüergen Thiele;Daniel A. Arber;Richard D. Brunning.
Blood (2009)

5187 Citations

Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia

Timothy J. Ley;Christopher Miller;Li Ding;Benjamin J. Raphael.
The New England Journal of Medicine (2013)

3697 Citations

Revised International Prognostic Scoring System for Myelodysplastic Syndromes

Peter L. Greenberg;Heinz Tuechler;Julie Schanz;Guillermo Sanz.
Blood (2012)

2252 Citations

The hMre11/hRad50 protein complex and Nijmegen breakage syndrome: linkage of double-strand break repair to the cellular DNA damage response.

James P Carney;James P Carney;Richard S Maser;Heidi Olivares;Elizabeth M Davis.
Cell (1998)

1389 Citations

BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros

Charles G. Mullighan;Christopher B. Miller;Ina Radtke;Letha A. Phillips.
Nature (2008)

1054 Citations

Prostate stem cell antigen: A cell surface marker overexpressed in prostate cancer

Robert E. Reiter;Zhennen Gu;Tetsuro Watabe;George Thomas.
Proceedings of the National Academy of Sciences of the United States of America (1998)

926 Citations

Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome.

Joshua Wechsler;Marianne Greene;Michael A. McDevitt;John Anastasi.
Nature Genetics (2002)

773 Citations

Subnuclear compartmentalization of immunoglobulin loci during lymphocyte development.

Steven T. Kosak;Jane A. Skok;Kay L. Medina;Roy Riblet.
Science (2002)

764 Citations

Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies

Omar Abdel-Wahab;Ann Mullally;Cyrus Hedvat;Guillermo Garcia-Manero.
Blood (2009)

706 Citations

Best Scientists Citing Michelle M. Le Beau

Hagop M. Kantarjian

Hagop M. Kantarjian

The University of Texas MD Anderson Cancer Center

Publications: 224

Ayalew Tefferi

Ayalew Tefferi

Mayo Clinic

Publications: 219

Guillermo Garcia-Manero

Guillermo Garcia-Manero

The University of Texas MD Anderson Cancer Center

Publications: 178

Mikkael A. Sekeres

Mikkael A. Sekeres

Cleveland Clinic

Publications: 151

Animesh Pardanani

Animesh Pardanani

Mayo Clinic

Publications: 133

Pierre Fenaux

Pierre Fenaux

Université Paris Cité

Publications: 133

Ross L. Levine

Ross L. Levine

Memorial Sloan Kettering Cancer Center

Publications: 130

Rhett P. Ketterling

Rhett P. Ketterling

Mayo Clinic

Publications: 120

Terra L. Lasho

Terra L. Lasho

Mayo Clinic

Publications: 116

Farhad Ravandi

Farhad Ravandi

The University of Texas MD Anderson Cancer Center

Publications: 115

Jorge E. Cortes

Jorge E. Cortes

Augusta University

Publications: 115

Alessandro M. Vannucchi

Alessandro M. Vannucchi

University of Florence

Publications: 112

Ulrich Germing

Ulrich Germing

Heinrich Heine University Düsseldorf

Publications: 111

Alan F. List

Alan F. List

Precision BioSciences

Publications: 110

Hartmut Döhner

Hartmut Döhner

University of Ulm

Publications: 107

Torsten Haferlach

Torsten Haferlach

MLL Munich Leukemia Laboratory

Publications: 102

Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking d-index is inferred from publications deemed to belong to the considered discipline.

If you think any of the details on this page are incorrect, let us know.

Contact us
Something went wrong. Please try again later.